IDRI, Zydus collaborate on leishmaniasis vaccine

India's Zydus Cadila and the Seattle, US-based non-profit health organization, Infectious Disease Research Institute (IDRI), are to collaborate to develop IDRI's visceral leishmaniasis (VL) vaccine candidate.

More from Anti-infective

More from Therapy Areas